Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
2
Total Settlement
$3M
2:18cv7476 • August 25, 2018
Class Period Start
May 1, 2017
Class Period End
August 7, 2018
PSLRA Deadline
October 24, 2018
Case Allegations
10b5
Statutes of Repose
May 1, 2020
Country
United States
Court
Federal Court
Jul 20, 2020
No Appeal- Closed
Jun 19, 2020
Motion to Dismiss Granted
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Feb 10, 2020
Motion to Dismiss
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Dec 10, 2019
First Amended Complaint
A new complaint has been filed on behalf of certain investors in Ampio Pharmaceuticals, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Oct 17, 2019
Scheduling Order
1:22cv2105 • August 17, 2022
Class Period Start
December 28, 2020
Class Period End
October 31, 2022
PSLRA Deadline
October 17, 2022
Case Allegations
10b5
Statutes of Repose
Dec 28, 2023
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
January 13, 2025
Settlement Fund
$3,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or otherwise acquired Ampio’s common stock between December 29, 2020 and August 2, 2022, inclusive.
Claim Administrator
Simpluris
P.O. Box 25226
Santa Ana, CA 92799
+1 833-602-5027
[email protected]
Settlement Website
https://www.ampiosecuritiessettlement.com/Hearing Date
February 19, 2025
Opt-out Deadline
January 29, 2025
Settlement Note
Download hereProof Of Claim
Download here
Mar 2, 2026
Disbursement Approved
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Feb 20, 2025
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Dec 23, 2024
Motion for Final Approval of Settlement
The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.
Oct 15, 2024
Notice of Pendency
Oct 15, 2024
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
TOP
